Sight Sciences, Inc.'s share price has fallen by -13.3% in the past 3 weeks, despite reporting a narrower-than-expected net loss in Q1 and sticking to its 2023 guidance. Sight Sciences' key Q1 2023 ...

Evercore ISI analyst Vijay Kumar raised the firm’s price target on Exact Sciences (EXAS) to $70 from $60 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech, Life ...

Piper Sandler analyst David Westenberg lowered the firm’s price target on Exact Sciences (EXAS) to $75 from $85 following quarterly results. The firm keeps an Overweight rating on the shares.

The average one-year price target for Kodiak Sciences (NasdaqGM:KOD) has been revised to $56.71 / share. This is an increase ...

BTIG analyst Mark Massaro lowered the firm’s price target on Exact Sciences (EXAS) to $65 from $82 and keeps a Buy rating on the shares. The company delivered a Q3 revenue miss and large guide-down, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

View Caris Life Sciences, Inc. CAI stock quote prices, financial information, real-time forecasts, and company news from CNN.

Click to deselect and select. Apr 13, 2026, 11:48 PM IST IST GSP Crop Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Apr 11, 2026, 11:54 PM IST IST GSP Crop ...